Edition:
United Kingdom

ASKA Pharmaceutical Co Ltd (4514.T)

4514.T on Tokyo Stock Exchange

1,089JPY
20 May 2019
Change (% chg)

¥24 (+2.25%)
Prev Close
¥1,065
Open
¥1,070
Day's High
¥1,092
Day's Low
¥1,067
Volume
57,500
Avg. Vol
95,868
52-wk High
¥1,642
52-wk Low
¥983

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 9,690.00 -16.715
Dec 13,539.00 52.171
Sep 10,716.00 -11.305
Jun 12,761.00 37.673
FY 2018 Mar '18 10,231.00 -22.635
Dec 13,659.00 49.065
Sep 12,241.00 21.289
Jun 12,813.00 37.076
FY 2017 Mar '17 11,052.00 -34.559
Dec 13,159.00 94.296
Sep 12,329.00 26.811
Jun 11,987.00 18.834
 
*Note: Units in Millions ofYen
**Note: Units in Yen

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 1 11,484.00 11,484.00 11,484.00 --
Year Ending Mar-19 1 48,500.00 48,500.00 48,500.00 --
Year Ending Mar-20 1 54,500.00 54,500.00 54,500.00 --
Year Ending Mar-21 1 57,500.00 57,500.00 57,500.00 --
Earnings (per share)
Year Ending Mar-19 1 58.40 58.40 58.40 --
Year Ending Mar-20 1 62.00 62.00 62.00 --
Year Ending Mar-21 1 143.40 143.40 143.40 --
Sales and Profit Figures in Japanese Yen (JPY);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 17.23 54.03 55.51
P/E High - Last 5 Yrs. 55.37 50.49 58.09
P/E Low - Last 5 Yrs. 15.50 27.02 28.17
Beta 0.92 0.97 0.96
Price to Sales (TTM) 0.70 7.48 9.49
Price to Book (MRQ) 0.69 3.44 4.12
Price to Tangible Book (MRQ) 1.16 3.75 4.94
Price to Cash Flow (TTM) 7.68 37.76 37.74
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield 1.31 1.88 1.69
Dividend Yield - 5 Year Avg 0.99 0.74 0.73
Dividend 5 Year Growth Rate 0.00 2.34 3.14
Payout Ratio(TTM) 11.30 16.20 15.84

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -5.29 12.90 15.47
Sales (TTM) vs TTM 1 Yr. Ago -4.57 6.11 8.33
Sales - 5 Yr. Growth Rate 3.41 9.35 10.55
EPS (MRQ) vs Qtr. 1 Yr. Ago 26.15 18.51 18.81
EPS (TTM) vs TTM 1 Yr. Ago -27.09 -- --
EPS - 5 Yr. Growth Rate 28.23 5.68 7.31
Capital Spending - 5 Yr. Growth Rate 50.94 7.37 8.46

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.32 2.39 2.41
Current Ratio (MRQ) 2.10 3.33 3.33
LT Debt to Equity (MRQ) 29.85 13.48 14.29
Total Debt to Equity (MRQ) 37.90 18.23 19.61
Interest Coverage (TTM) -- 8.57 14.97

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 40.45 51.83 50.23
Gross Margin - 5 Yr. Avg. 39.52 50.41 51.03
EBITD Margin (TTM) 9.15 -- --
EBITD - 5 Yr. Avg 8.65 17.36 15.85
Operating Margin (TTM) 3.38 0.31 -5.48
Operating Margin - 5 Yr. Avg. 4.21 13.52 11.05
Pre-Tax Margin (TTM) 4.03 -0.00 -5.74
Pre-Tax Margin - 5 Yr. Avg. 4.94 19.70 16.06
Net Profit Margin (TTM) 3.74 -3.70 -9.55
Net Profit Margin - 5 Yr. Avg. 3.88 14.80 11.26
Effective Tax Rate (TTM) 7.33 20.31 20.60
Effective Tax Rate - 5 Yr. Avg. 21.47 22.43 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 856,648,057 719,019,170
Net Income/Employee (TTM) -- 100,100,167 83,985,523
Receivable Turnover (TTM) 4.36 5.29 5.61
Inventory Turnover (TTM) 2.15 2.47 3.67
Asset Turnover (TTM) 0.63 0.81 0.77

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 2.35 9.58 9.33
Return on Assets - 5 Yr. Avg. 2.83 10.78 10.30
Return on Investment (TTM) 3.00 11.89 11.59
Return on Investment - 5 Yr. Avg. 3.64 13.74 13.13
Return on Equity (TTM) 4.06 13.19 16.33
Return on Equity - 5 Yr. Avg. 4.64 15.07 14.72
  1 Year 3 Year 5 Year
Sales % -4.57 2.62 3.41
EPS (TTM) % -27.09 34.96 28.23
Dividend % 0.00 0.00 0.00
Note: Units in Millions of US Dollars

Performance for ASKA Pharmaceutical Co Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.67 -1.86 88 19
13 Week -10.43 -9.10 63 8
26 Week -11.54 -7.27 87 10
52 Week -22.66 -10.01 84 55
YTD -3.88 -7.60 83 14
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 25.50%
# of Holders: 57
Total Shares Held: 7,793,738
3 Mo. Net Change: 31,851
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 8
# Reduced Positions: 6
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.